These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33289947)

  • 1. Imaging Cerebral Glucose Metabolism during Dual-Task Walking in Patients with Parkinson's disease.
    Szturm T; Beheshti I; Mahana B; Hobson DE; Goertzen A; Ko JH
    J Neuroimaging; 2021 Mar; 31(2):356-362. PubMed ID: 33289947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Metabolic Activity and Gait Function by Dual-Task Cognitive Game-Based Treadmill System in Parkinson's Disease: Protocol of a Randomized Controlled Trial.
    Szturm T; Kolesar TA; Mahana B; Goertzen AL; Hobson DE; Marotta JJ; Strafella AP; Ko JH
    Front Aging Neurosci; 2021; 13():680270. PubMed ID: 34149399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
    Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Frontal Lobe in Complex Walking Among Patients With Parkinson's Disease and Healthy Older Adults: An fNIRS Study.
    Maidan I; Nieuwhof F; Bernad-Elazari H; Reelick MF; Bloem BR; Giladi N; Deutsch JE; Hausdorff JM; Claassen JA; Mirelman A
    Neurorehabil Neural Repair; 2016 Nov; 30(10):963-971. PubMed ID: 27221042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dual-task in patients with Parkinson's disease performing cognitive-motor paradigms.
    Hsiu-Chen C; Chiung-Chu C; Jiunn-Woei L; Wei-Da C; Yi-Hsin W; Ya-Ju C; Chin-Song L
    J Clin Neurosci; 2020 Feb; 72():72-78. PubMed ID: 31952973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual hallucination in Parkinson's disease with FDG PET.
    Nagano-Saito A; Washimi Y; Arahata Y; Iwai K; Kawatsu S; Ito K; Nakamura A; Abe Y; Yamada T; Kato T; Kachi T
    Mov Disord; 2004 Jul; 19(7):801-806. PubMed ID: 15254938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
    Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
    Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.
    Teune LK; Renken RJ; de Jong BM; Willemsen AT; van Osch MJ; Roerdink JB; Dierckx RA; Leenders KL
    Neuroimage Clin; 2014; 5():240-4. PubMed ID: 25068113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral glucose metabolism in Parkinson's disease with dementia].
    Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.
    Smith GS; Mills KA; Pontone GM; Anderson WS; Perepezko KM; Brasic J; Zhou Y; Brandt J; Butson CR; Holt DP; Mathews WB; Dannals RF; Wong DF; Mari Z
    Parkinsonism Relat Disord; 2019 Jul; 64():235-241. PubMed ID: 31053531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Wang X; Zhang J; Yuan Y; Li T; Zhang L; Ding J; Jiang S; Li J; Zhu L; Zhang K
    Neurosci Lett; 2017 Jul; 653():202-207. PubMed ID: 28579485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    Kim HW; Oh M; Oh JS; Oh SJ; Lee SJ; Chung SJ; Kim JS
    PLoS One; 2017; 12(1):e0169928. PubMed ID: 28085923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease.
    Arnaldi D; Meles SK; Giuliani A; Morbelli S; Renken RJ; Janzen A; Mayer G; Jonsson C; Oertel WH; Nobili F; Leenders KL; Pagani M;
    J Parkinsons Dis; 2019; 9(1):229-239. PubMed ID: 30741687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease.
    Lee MS; Lyoo CH; Ryu YH; Lim HS; Nam CM; Kim HS; Rinne JO
    Acta Neurol Scand; 2011 Sep; 124(3):196-201. PubMed ID: 20880270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Differential Effects of 2 Forms of Exercise on Prefrontal Plasticity During Walking in Parkinson's Disease.
    Maidan I; Nieuwhof F; Bernad-Elazari H; Bloem BR; Giladi N; Hausdorff JM; Claassen JAHR; Mirelman A
    Neurorehabil Neural Repair; 2018 Mar; 32(3):200-208. PubMed ID: 29546797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH
    Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
    Huang C; Ravdin LD; Nirenberg MJ; Piboolnurak P; Severt L; Maniscalco JS; Solnes L; Dorfman BJ; Henchcliffe C
    Dement Geriatr Cogn Disord; 2013; 35(3-4):183-96. PubMed ID: 23445555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.